UBS AG

  • WKN: UB0BL6
  • ISIN: CH0024899483
  • Land: Switzerland

Nachricht vom 15.08.2012 | 09:32

UBS AG: Release according to Article 30e of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


UBS AG  / New loan issues and their warranties according to § 30e Para.
1, No. 2 of the WpHG [the German Securities Trading Act]

15.08.2012 09:32

Dissemination of a Post-admission Duties announcement according to Article
30e Para. 1, No. 2 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


UBS AG, acting through its Stamford Branch, issued a 7.625% fixed rate
public subordinated bond in the amount of USD 2.0bn, ISIN US90261AAB89,
maturing on 17 August 2022 and payment date on 17 August 2012.

This notice is not an offer to purchase the securities mentioned herein and
is made for information purposes only.

Information about UBS bonds is available under:
http://www.ubs.com/1/e/investors/debt.html



15.08.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      UBS AG
              Bahnhofstrasse 45
              8001 Zürich
              Switzerland
Internet:     www.ubs.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Event im Fokus

38. m:access Analystenkonferenz München

Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München



Aktuelle Research-Studie

MOLOGEN AG

Original-Research: Mologen AG (von Montega AG): Kaufen

24. Mai 2013